Is there a difference in phenotype between males and females with non-transfusion-dependent thalassemia? A cross-sectional evaluation.

about

Is there a difference in phenotype between males and females with non-transfusion-dependent thalassemia? A cross-sectional evaluation.

Item

http://www.wikidata.org/entity/Q47206772

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Is there a difference in pheno ...... A cross-sectional evaluation.

@en

Is there a difference in pheno ...... A cross-sectional evaluation.

@nl

type

Item

label

Is there a difference in pheno ...... A cross-sectional evaluation.

@en

Is there a difference in pheno ...... A cross-sectional evaluation.

@nl

prefLabel

Is there a difference in pheno ...... A cross-sectional evaluation.

@en

Is there a difference in pheno ...... A cross-sectional evaluation.

@nl

P1476

Is there a difference in pheno ...... A cross-sectional evaluation.

@en

P2093

Aldo Filosa

http://www.w3.org/2001/XMLSchema#string

Alessia Pepe

http://www.w3.org/2001/XMLSchema#string

Maria Marsella

http://www.w3.org/2001/XMLSchema#string

Massimiliano Ammirabile

http://www.w3.org/2001/XMLSchema#string

Silvia Costantini

http://www.w3.org/2001/XMLSchema#string

Tiziana Di Matola

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.

The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages.

Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.

Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature.

Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.

Morbidities in non-transfusion-dependent thalassemia.

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone.

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2017.1413789

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Ricchi

P577

2018-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29303050

http://www.w3.org/2001/XMLSchema#string